These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19232014)

  • 61. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
    Choplin N; Bernstein P; Batoosingh AL; Whitcup SM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
    Noecker RJ; Walt JG
    Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S15-21. PubMed ID: 16389056
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of topical prostaglandin analog use on outcome following selective laser trabeculoplasty.
    Scherer WJ
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):503-12. PubMed ID: 17941809
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
    Cantor LB; Hoop J; Morgan L; Wudunn D; Catoira Y;
    Br J Ophthalmol; 2006 Nov; 90(11):1370-3. PubMed ID: 16825272
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The impact of common classes of topical antiglaucoma medications on central corneal thickness--own observations.
    Wierzbowska J; Łagocka A; Siemiatkowska A; Robaszkiewicz J; Stankiewicz A; Sierdziński J
    Klin Oczna; 2009; 111(10-12):323-6. PubMed ID: 20169887
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.
    Simmons ST; Bernstein P; Hollander DA
    Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Axial length of the ocular globe and hypotensive effect in glaucoma therapy with prostaglandin analogs].
    Stefan C; Nenciu A; Malcea C; Tebeanu E
    Oftalmologia; 2005; 49(4):47-50. PubMed ID: 16524126
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Receptors involved in the mechanism of action of topical prostaglandines].
    Neacsu AM
    Oftalmologia; 2009; 53(2):3-7. PubMed ID: 19697832
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.
    Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment.
    Rodrigues Mde L; Felipe Crosta DP; Soares CP; Deghaide NH; Duarte R; Sakamoto FS; Furtado JM; Paula JS; Donadi EA; Soares EG
    J Glaucoma; 2009 Mar; 18(3):197-200. PubMed ID: 19295371
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea.
    Hariharan S; Minocha M; Mishra GP; Pal D; Krishna R; Mitra AK
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):487-98. PubMed ID: 20028257
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of investigator bias in industry-funded clinical trials of latanoprost.
    Jinapriya D; Anraku A; Alasbali T; Trope GE; Buys YM
    Can J Ophthalmol; 2011 Dec; 46(6):531-6. PubMed ID: 22153642
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.
    Sonty S; Donthamsetti V; Vangipuram G; Ahmad A
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):517-20. PubMed ID: 18800869
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
    Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
    Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Fixed combination of topical prostaglandin analogue in glaucoma treatment].
    Stefan C; Pop A; Cojocaru I
    Oftalmologia; 2011; 55(3):82-8. PubMed ID: 22428296
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma.
    Chen MJ; Chen YC; Chou CK; Hsu WM
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):559-66. PubMed ID: 18001247
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
    Konstas AG; Katsimbris JM; Lallos N; Boukaras GP; Jenkins JN; Stewart WC
    Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.